|
Post by mannmade on Jan 17, 2019 10:47:03 GMT -5
Should also send to every doctor you know.
|
|
|
Post by cretin11 on Jan 17, 2019 17:18:39 GMT -5
What an outstanding video. Descriptive, succinct, accurate, compelling. Need to get more eyeballs on this, especially docs and PWDs!
|
|
|
Post by kc on Jan 17, 2019 17:27:43 GMT -5
If you order the book, be sure to get the latest edition. Earlier editions do not have chapters on Afrezza. Amazon has the December 2017 edition on their site. Is that the current one?
|
|
|
Post by Clement on Jan 17, 2019 17:37:08 GMT -5
If you order the book, be sure to get the latest edition. Earlier editions do not have chapters on Afrezza. Amazon has the December 2017 edition on their site. Is that the current one? Gee, I hope so. That's what I ordered. I did the "look inside" on Amazon and did not find chapters on Afrezza, but in small print it was explained that the "look inside" was a previous edition. After I get the book this weekend, I will try to post to let you know whether my edition has the chapters on Afrezza.
|
|
|
Post by mnkdorbust on Jan 17, 2019 19:50:20 GMT -5
If you order the book, be sure to get the latest edition. Earlier editions do not have chapters on Afrezza. Amazon has the December 2017 edition on their site. Is that the current one? As long as you got the 5th edition you should be good as that seems to be the most current according to the TCOYD site. tcoyd.org/tcoyd-book/
|
|
|
Post by itellthefuture777 on Jan 18, 2019 0:43:01 GMT -5
Separately, Cummings is also holding a hearing at the end of the month that will serve to launch a "broad review of the skyrocketing prices of prescription drugs."
Witnesses have not been announced, but they are expected to be industry experts and analysts, rather than company executives.
Hmmm..
|
|
|
Post by sayhey24 on Jan 18, 2019 8:17:10 GMT -5
Someone needs to get to Cummings prior and tell the Afrezza story and that MNKD is now selling direct for $4 a day. They also need to highlight that federal law allowing human insulin to be sold OTC and afrezza should fall under that law. Cumming's should take an action item and spearhead that BP does not stand in the way of selling afrezza OTC.
|
|
|
Post by dh4mizzou on Jan 18, 2019 8:36:57 GMT -5
|
|
|
Post by Clement on Jan 20, 2019 11:09:00 GMT -5
Amazon has the December 2017 edition on their site. Is that the current one? Gee, I hope so. That's what I ordered. I did the "look inside" on Amazon and did not find chapters on Afrezza, but in small print it was explained that the "look inside" was a previous edition. After I get the book this weekend, I will try to post to let you know whether my edition has the chapters on Afrezza. I received the book late yesterday. Taking Control of Your Diabetes, 5th Edition. It specifically states copyright 2018 after the title page. According to the publishers website (pcibooks.com), the 5th edition is the latest. Afrezza shows up on eight different pages. When talking about mealtime insulins, Edelman describes the RAAs as "fast-acting". Then there is one paragraph with the heading "Faster-Acting Aspart: Fiasp". Then there are a few pages about Afrezza with the heading "Ultra-Rapid-Acting Inhaled Insulin".
|
|
|
Post by slugworth008 on Jan 20, 2019 23:39:18 GMT -5
One of my fav munchies is - A bowl of Nacho Cheese Doritos with shredded cheddar mixed in and nuked - then topped with diced black olives and jalepenos
Mas Bueno!!
|
|
|
Post by MnkdWASmyRtrmntPlan on Jan 21, 2019 14:23:38 GMT -5
Gee, I hope so. That's what I ordered. I did the "look inside" on Amazon and did not find chapters on Afrezza, but in small print it was explained that the "look inside" was a previous edition. After I get the book this weekend, I will try to post to let you know whether my edition has the chapters on Afrezza. I received the book late yesterday. Taking Control of Your Diabetes, 5th Edition. It specifically states copyright 2018 after the title page. According to the publishers website (pcibooks.com), the 5th edition is the latest. Afrezza shows up on eight different pages. When talking about mealtime insulins, Edelman describes the RAAs as "fast-acting". Then there is one paragraph with the heading "Faster-Acting Aspart: Fiasp". Then there are a few pages about Afrezza with the heading "Ultra-Rapid-Acting Inhaled Insulin". Thanks for the info, Clement. I'm not sure about the Ultra-Rapid thing, though. It is good that Edelman gives RAA, Fiasp and Afrezza the labels of good, gooder and goodest . We need to have a faster category than Fiasp. If we can get enough respected diabetes leaders referring to Afrezza as its own special class of speed, maybe that will help push the door open to coerce the ADA to create a special category for it. I think it's amusing that he calls it Ultra-Rapid though. Not just insulin; Fast insulin. Not just Fast; Ultra Fast. Not just Ultra Fast; Ultra Rapid. Hey, wait. Which is faster, Fast or Rapid? Let's check with Daniel ... Rapid= moving or occurring speedily, swift, (usually involves speed). The river was flowing at a rapid rate and rapidly overflowed its banks. Fast= happening quickly, although usually used in comparison to something else. I was worried because the town was flooding so fast that people couldn't escape.We want to indicate that it is Faster than Fast insulin, so we are comparing it. Therefore, Fast would be more appropriate than Rapid per Mr. Webster. I also think that introducing the word Rapid would just be confusing because people would wonder, just as I did, which is faster: Fast or Rapid? So, hey, ADA, my vote is for Ultra-Fast-Acting. Say, Clement, were Edelman's comments about Afrezza good, gooder or great? Seriously, did he write good things about it, or just blah. I'm just wondering if he felt under the pressure/influence of BP when writing the book.
|
|
|
Post by goyocafe on Jan 21, 2019 14:34:32 GMT -5
I received the book late yesterday. Taking Control of Your Diabetes, 5th Edition. It specifically states copyright 2018 after the title page. According to the publishers website (pcibooks.com), the 5th edition is the latest. Afrezza shows up on eight different pages. When talking about mealtime insulins, Edelman describes the RAAs as "fast-acting". Then there is one paragraph with the heading "Faster-Acting Aspart: Fiasp". Then there are a few pages about Afrezza with the heading "Ultra-Rapid-Acting Inhaled Insulin". Thanks for the info, Clement. I'm not sure about the Ultra-Rapid thing, though. It is good that Edelman gives RAA, Fiasp and Afrezza the labels of good, gooder and goodest . We need to have a faster category than Fiasp. If we can get enough respected diabetes leaders referring to Afrezza as its own special class of speed, maybe that will help push the door open to coerce the ADA to create a special category for it. I think it's amusing that he calls it Ultra-Rapid though. Not just insulin; Fast insulin. Not just Fast; Ultra Fast. Not just Ultra Fast; Ultra Rapid. Hey, wait. Which is faster, Fast or Rapid? Let's check with Daniel ... Rapid= moving or occurring speedily, swift, (usually involves speed). The river was flowing at a rapid rate and rapidly overflowed its banks. Fast= happening quickly, although usually used in comparison to something else. I was worried because the town was flooding so fast that people couldn't escape.We want to indicate that it is Faster than Fast insulin, so we are comparing it. Therefore, Fast would be more appropriate than Rapid per Mr. Webster. I also think that introducing the word Rapid would just be confusing because people would wonder, just as I did, which is faster: Fast or Rapid? So, hey, ADA, my vote is for Ultra-Fast-Acting. Say, Clement, were Edelman's comments about Afrezza good, gooder or great? Seriously, did he write good things about it, or just blah. I'm just wondering if he felt under the pressure/influence of BP when writing the book. “Fastest Acting”
|
|
|
Post by peppy on Jan 21, 2019 14:35:55 GMT -5
I received the book late yesterday. Taking Control of Your Diabetes, 5th Edition. It specifically states copyright 2018 after the title page. According to the publishers website (pcibooks.com), the 5th edition is the latest. Afrezza shows up on eight different pages. When talking about mealtime insulins, Edelman describes the RAAs as "fast-acting". Then there is one paragraph with the heading "Faster-Acting Aspart: Fiasp". Then there are a few pages about Afrezza with the heading "Ultra-Rapid-Acting Inhaled Insulin". Thanks for the info, Clement. I'm not sure about the Ultra-Rapid thing, though. It is good that Edelman gives RAA, Fiasp and Afrezza the labels of good, gooder and goodest . We need to have a faster category than Fiasp. If we can get enough respected diabetes leaders referring to Afrezza as its own special class of speed, maybe that will help push the door open to coerce the ADA to create a special category for it. I think it's amusing that he calls it Ultra-Rapid though. Not just insulin; Fast insulin. Not just Fast; Ultra Fast. Not just Ultra Fast; Ultra Rapid. Hey, wait. Which is faster, Fast or Rapid? Let's check with Daniel ... Rapid= moving or occurring speedily, swift, (usually involves speed). The river was flowing at a rapid rate and rapidly overflowed its banks. Fast= happening quickly, although usually used in comparison to something else. I was worried because the town was flooding so fast that people couldn't escape.We want to indicate that it is Faster than Fast insulin, so we are comparing it. Therefore, Fast would be more appropriate than Rapid per Mr. Webster. I also think that introducing the word Rapid would just be confusing because people would wonder, just as I did, which is faster: Fast or Rapid? So, hey, ADA, my vote is for Ultra-Fast-Acting. Say, Clement, were Edelman's comments about Afrezza good, gooder or great? Seriously, did he write good things about it, or just blah. I'm just wondering if he felt under the pressure/influence of BP when writing the book. Edelman uses afrezza and as a physician, he gets to write his own prescriptions. Doctor, if you or your family member had type one diabetes, which insulin would you use?
|
|
|
Post by MnkdWASmyRtrmntPlan on Jan 21, 2019 14:42:13 GMT -5
Thanks for the info, Clement. I'm not sure about the Ultra-Rapid thing, though. It is good that Edelman gives RAA, Fiasp and Afrezza the labels of good, gooder and goodest . We need to have a faster category than Fiasp. If we can get enough respected diabetes leaders referring to Afrezza as its own special class of speed, maybe that will help push the door open to coerce the ADA to create a special category for it. I think it's amusing that he calls it Ultra-Rapid though. Not just insulin; Fast insulin. Not just Fast; Ultra Fast. Not just Ultra Fast; Ultra Rapid. Hey, wait. Which is faster, Fast or Rapid? Let's check with Daniel ... Rapid= moving or occurring speedily, swift, (usually involves speed). The river was flowing at a rapid rate and rapidly overflowed its banks. Fast= happening quickly, although usually used in comparison to something else. I was worried because the town was flooding so fast that people couldn't escape.We want to indicate that it is Faster than Fast insulin, so we are comparing it. Therefore, Fast would be more appropriate than Rapid per Mr. Webster. I also think that introducing the word Rapid would just be confusing because people would wonder, just as I did, which is faster: Fast or Rapid? So, hey, ADA, my vote is for Ultra-Fast-Acting. Say, Clement, were Edelman's comments about Afrezza good, gooder or great? Seriously, did he write good things about it, or just blah. I'm just wondering if he felt under the pressure/influence of BP when writing the book. “Fastest Acting” Yeah, that's good. Short of IV, there probably never will be anything faster than Afrezza.
|
|
|
Post by mango on Jan 21, 2019 15:38:14 GMT -5
I think Eli Lilly is calling their RAA that's currently in clinical trials, Ultra Rapid.
Looks like they're trying to pull what Novo did.
These people are stupid.
|
|